🔎 Trials Near Me

Utama › Kejang › Michigan

Kajian klinikal Kejang di Michigan

7 kajian untuk Kejang sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Wayne State University, Detroit
  • Corewell Health, Grand Rapids
Mengambil pesertaFasa 1
Umur 12 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Wayne State University - Detroit Medical Center, Detroit
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06798896

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

  • C.S. Mott Children's Hospital, Ann Arbor
Mengambil pesertaKajian pemerhatian
Sehingga umur 26 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05374824

Outcomes After Planned Discontinuation of AntiSeizure Medication

  • University of Michigan, Ann Arbor
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07750496

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program, Detroit
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • 9D University Health Center, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT05716100

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Michigan, Ann Arbor
Mengambil pesertaFasa 3
6 Months – 13 Years · Semua jantina · Dikemas kini 30 Sep 2025 · NCT05121324

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.